Australia markets close in 4 hours 32 minutes

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.51-0.02 (-0.08%)
At close: 04:00PM EDT
24.51 0.00 (0.00%)
After hours: 04:10PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
250,725
219,788
137,039
94,085
62,649
-
Cost of revenue
48,694
44,982
32,009
15,822
9,685
-
Gross profit
202,031
174,806
105,030
78,263
52,964
-
Operating expenses
Research development
53,034
53,618
44,903
29,646
13,256
-
Selling general and administrative
181,885
180,152
143,003
86,738
48,132
-
Total operating expenses
243,957
242,783
196,172
118,342
59,506
-
Operating income or loss
-41,926
-67,977
-91,142
-40,079
-6,542
-
Interest expense
21
11
17
1
2,634
-
Total other income/expenses net
-
-
18,287
-
-1,397
2,280
Income before tax
-30,664
-57,365
-68,904
-40,012
-10,200
-
Income tax expense
132
101
-1,766
-8,720
84
-
Income from continuing operations
-30,796
-57,466
-67,138
-31,292
-10,284
-
Net income
-30,796
-57,466
-67,138
-31,292
-10,284
-
Net income available to common shareholders
-30,796
-57,466
-67,138
-31,292
-10,284
-
Basic EPS
-2.84
-
-2.58
-1.24
-0.54
0.35
Diluted EPS
-2.84
-
-2.58
-1.24
-0.54
-0.21
Basic average shares
26,644
-
26,054
25,137
18,929
8,584
Diluted average shares
26,644
-
26,054
25,137
18,929
8,658